Study of biomarkers in lichen planus
Part of Skin clinical trials.
This study looks at people with lichen planus (a rash that can affect skin, mouth, or genitals) to find markers in cells and blood that may help understand the disease. If you have a new diagnosis or a flare-up, and you are not on strong immune-suppressing medicine, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of lichen planus or are having a flare-up of symptoms.
- You are not currently on any systemic treatment (like steroids or immune-suppressing drugs), or you have stopped them recently.
- Your lichen planus is not only on skin folds (like armpits or groin) or on your face.
- You are able to give written consent and understand spoken and written French.
- You are covered by French social security or a similar health insurance plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study looks at whether people with oral lichen planus have a higher risk of heart problems or blood clots. It may help understand if more monitoring is needed.
This trial looks at a protein called Interleukin-4 in patients with Pityriasis Lichenoides Chronica (PLC), a skin condition with bumps or light-colored spots. The goal is to better understand the condition and find new ways to help.
This study looks at a protein (called desmoglein-3) in the tissue of people with oral lichen planus (OLP), especially the painful, red, or blistering forms. It aims to see if this protein is linked to how severe the disease is, which could help in understanding and treating OLP better.
This trial tests two light-based treatments (photobiomodulation and photodynamic therapy) and a steroid cream (clobetasol) for painful oral lichen planus. The goal is to see which treatment works best to reduce mouth sores and discomfort.
Hear when a new Lichen Planus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.